Package 0031-8719-20

{"route": ["ORAL"], "spl_id": "cb5018d5-8b32-41b8-a393-008d092d4638", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1111663"], "spl_set_id": ["868ac65a-63e2-46ac-b87d-66b289086756"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 BLISTER PACK in 1 CARTON (0031-8719-10)  / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK", "package_ndc": "0031-8719-10", "marketing_start_date": "20160502"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (0031-8719-20)  / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK", "package_ndc": "0031-8719-20", "marketing_start_date": "20130523"}], "brand_name": "Robitussin Maximum Strength Cough Plus Chest Congestion DM", "product_id": "0031-8719_cb5018d5-8b32-41b8-a393-008d092d4638", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "0031-8719", "generic_name": "dextromethorphan hydrobromide and guaifenesin", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Robitussin Maximum Strength Cough Plus Chest Congestion DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20130523", "listing_expiration_date": "20271231"}